ReWalk Robotics Ltd. (NASDAQ: LFWD) reported Q2 EPS of ($0.42), $0.13 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $6.65 million.

GUIDANCE:

ReWalk Robotics Ltd. sees FY2024 revenue of $28-32 million, versus the consensus of $30.66 million.
Based on the expanded access to ReWalk systems from the recently established Medicare coverage and continued improvement of sales traction by the new commercial team, Lifeward expects sequential improvement in quarterly revenue through the rest of 2024.

For earnings history and earnings-related data on ReWalk Robotics Ltd. (LFWD) click here.